Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Wants Comparative Effectiveness Studies on Long-Acting Anti-Psychotics

This article was originally published in The Pink Sheet Daily

Executive Summary

The Institute of Medicine's report on CE priorities, to be released June 30, may shape agenda across a number of product categories.

You may also be interested in...



J&J Takes Leaner, But Stronger Business Approach With Management Consolidation

The health care giant is eliminating some management positions with more organizational announcements expected in coming weeks.

J&J Takes Leaner, But Stronger Business Approach With Management Consolidation

The health care giant is eliminating some management positions with more organizational announcements expected in coming weeks.

J&J CNS Studies Show Awareness Of CER And Broader Databases

J&J's proposal to make long-acting anti-psychotic drugs a priority for the nation's push into comparative effectiveness research didn't make it onto the Institute of Medicine's "hot list" of research priorities released June 30 (1"The Pink Sheet" DAILY, June 30, 2009)

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS069619

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel